SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027955
Filing Date
2016-11-07
Accepted
2016-11-07 16:17:57
Documents
54
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-10q_20160930.htm 10-Q 1687427
2 EX-31.1 dvax-ex311_14.htm EX-31.1 18077
3 EX-31.2 dvax-ex312_15.htm EX-31.2 18007
4 EX-32.1 dvax-ex321_13.htm EX-32.1 6205
5 EX-32.2 dvax-ex322_12.htm EX-32.2 6267
  Complete submission text file 0001564590-16-027955.txt   5889157

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dvax-20160930.xml EX-101.INS 1322663
7 XBRL TAXONOMY EXTENSION SCHEMA dvax-20160930.xsd EX-101.SCH 33249
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dvax-20160930_cal.xml EX-101.CAL 45534
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dvax-20160930_def.xml EX-101.DEF 126388
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dvax-20160930_lab.xml EX-101.LAB 320453
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dvax-20160930_pre.xml EX-101.PRE 237930
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

IRS No.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 161978332
SIC: 2834 Pharmaceutical Preparations